Literature DB >> 11391343

Current efficacy of postexposure prophylaxis against measles with immunoglobulin.

A Endo1, H Izumi, M Miyashita, K Taniguchi, O Okubo, K Harada.   

Abstract

We assessed results after postexposure prophylaxis against measles with immunoglobulin administered intramuscularly. Children were given 0.33 mL/kg of immunoglobulin from commercially available lots containing various titers of measles antibody within 5 days after exposure. In children receiving immunoglobulin with a titer of < or =16 IU/mL, 57% had clinically evident measles. Immunoglobulin preparations with higher measles antibody titers are required.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11391343     DOI： 10.1067/mpd.2001.113710

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  9 in total

Review 1.  Measles virus, immune control, and persistence.

Authors:  Diane E Griffin; Wen-Hsuan Lin; Chien-Hsiung Pan
Journal:  FEMS Microbiol Rev       Date:  2012-03-13       Impact factor: 16.408

2.  Protective immunity following vaccination: how is it defined?

Authors:  Ian J Amanna; Ilhem Messaoudi; Mark K Slifka
Journal:  Hum Vaccin       Date:  2008-02-19

3.  Do Australian immunoglobulin products meet international measles antibody titer standards?

Authors:  Megan K Young; Joseph Bertolini; Pushpa Kotharu; Darryl Maher; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2016-10-20       Impact factor: 3.452

4.  Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination.

Authors:  Laura Papetti; Maria Elisa Amodeo; Letizia Sabatini; Melissa Baggieri; Alessandro Capuano; Federica Graziola; Antonella Marchi; Paola Bucci; Emilio D'Ugo; Maedeh Kojouri; Silvia Gioacchini; Carlo Efisio Marras; Carlotta Ginevra Nucci; Fabiana Ursitti; Giorgia Sforza; Michela Ada Noris Ferilli; Gabriele Monte; Romina Moavero; Federico Vigevano; Massimiliano Valeriani; Fabio Magurano
Journal:  Viruses       Date:  2022-03-31       Impact factor: 5.818

Review 5.  Wanted, dead or alive: new viral vaccines.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

Review 6.  Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to next.

Authors:  Megan K Young; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2013-06-19       Impact factor: 3.452

7.  Updated NACI recommendations for measles post-exposure prophylaxis.

Authors:  M C Tunis; M I Salvadori; V Dubey; O Baclic
Journal:  Can Commun Dis Rep       Date:  2018-09-06

8.  Postexposure management of healthcare personnel to infectious diseases.

Authors:  Mazen S Bader; Annie A Brooks; Jocelyn A Srigley
Journal:  Hosp Pract (1995)       Date:  2015-03-01

Review 9.  Public health responses during measles outbreaks in elimination settings: Strategies and challenges.

Authors:  Paul A Gastañaduy; Emily Banerjee; Chas DeBolt; Pamela Bravo-Alcántara; Samia A Samad; Desiree Pastor; Paul A Rota; Manisha Patel; Natasha S Crowcroft; David N Durrheim
Journal:  Hum Vaccin Immunother       Date:  2018-07-11       Impact factor: 3.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.